Immunological and biochemical markers in oral carcinogenesis: The public health perspective

International Journal of Environmental Research and Public Health

Volumn 5, Issue 5, 2008, Pages 418-422

  Khanna, Sunali ^a  

^a NAIR HOSPITAL DENTAL COLLEGE   (India)

Author keywords

Copper; Dental public healths; Immune complexes; India; Iron; Precancerous condition; Selenium; Trace elements

Indexed keywords

COPPER; IRON; SELENIUM; TUMOR MARKER;

ADULT; AGED; ANTIGEN ANTIBODY COMPLEX; CANCER PATIENT; CARCINOGENESIS; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COPPER BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; HUMAN; IRON BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; PRECANCER; PUBLIC HEALTH; RANDOMIZED CONTROLLED TRIAL;

NICOTIANA TABACUM;

EID: 58849151161     PISSN: None     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph5050418     Document Type: Conference Paper

References (33)

1. Peterson, P. E.: Global Research Challenges, Updated on Global Forum for Health Research, 2008, Vol-2, 181-184.
2. Petersen, P. E.: The World Oral Health Report 2003: Continuous improvement of oral health in the 21st century - the approach of the WHO Global Oral Health Programme. Community, Dent Oral Epidemiology, 2003, 31(Suppl 1):3-24.
3. Khanna, S.; Karjodkar, F. R.: Immunological & Biochemical markers in oral precancer and cancer. J. of Head & Face Medicine Biomedcentral, 2006, 33(2).
4. Competency Statement for Dental Public Health. American Association of Public Health Dentistry (AAPHD). Available at http://www.aaphd.org, Accessed: August 6, 2007.
5. Allukian, M.: The Neglected Epidemic and Surgeon General's Report: A Call to Action for Better Oral Health (editorial). Am J. Public Health, 2000, 90(6), 843-45.
6. Cohen, L.; Gift, H. C.: Socio-Dental sciences in Action. Disease prevention and health promotion, Munksgard, Copenhagen: Federation Dentaire International, 1995, 109-52
7. Garcia, G. R. I.: Multicultural issues in oral health, Dental Clinics of North America, 2008, 52, 319-332.
8. Life expectancy in our nation, 2008, India together.com
9. India Country health system profile - World Health Organization, 2007.
10. Khanna, Sunali; Mehta Payal: Geriatric Oral Health: the Indian scenario. Ageing & Society Indian Journal of Gerontology, 16(2), 159.
11. Agency for health care research and quality. National healthcare disparities report. USDHHS Pub. No. 04-0035, Rockville (MD): AHRQ, 2003
12. Bouquot, J. E.; Whitaker, S. B.: Oral Leukoplakia rationale for diagnosis and prognosis of its clinical subtypes or "phases". Quintessence Int., 1994, 25, 133-140.
13. Chen, J.; Eiserberg, E.: Changing trends in oral cancer in United States 1935-1985. A Connecticut Study. J. Oral Maxillofac Surg. 1991, 49, 1152-1158
14. Ostman, J.; Anneroth, E: Malignant oral tumours in Sweden 1962-1989. An Epidemiological Study. Eu. J. Cancer & Oral Oncology 1995, 8, 106-112.
15. Gupta, P. C.: Leukoplakia and the incidence of oral cancer. J. Oral Pathol Med. 1989, 18, 11.
16. Babu, S.; Bhat, R. V.; Kumar, P. V.; Sesikaran, B.; Rao, K. V.; Aruna, P.; Reddy, P. R.: A comparative clinopathological study of OSMF in habitual chewers of pan masala and betel quid. Clin. Toxicology 1996, 34(3).
17. Spermulli, V. N.; Dexter, D. L.: Human tumour cell heterogenecity and metastasis. J. Clin Oncology, 1983, 1, 496.
18. Salinas, F. A.; Kian Wee; Silver HK.: Tumour burden and its relationship to antigen, size and composition of IC, In: Protides of the biological fluids (H Peters) ed. Pergamon Press Oxford: 1984; Vol. 31, pp. 749-752
19. Mills, C. F.; Davis, G. K.: Molybdenum. In: W. Mertz, Editor, Trace elements in human and animal nutrition. (5th ed), Academic Press, New York: 1987, pp. 429-463.
20. Schwartz, M. F.: Role of Trace elements in Cancer. Cancer Research 1975; 35, 3481-87.
21. Riha, I.: The use of polyethyleneglycol for immune complex detection in human sera. Immunol. 1979, 16, 489.
22. th ed.), 1988, 622-634.
23. Raghunath, R.: Studies on environmental levels of toxic metals and their exposure assessment in Greater Bombay PhD Thesis, Envt. Assessment Divs BARC, 1996.
24. Lichenstein: Comparison of immune derangements in patients with different malignancies. Cancer, 1980, 45: 2090-5.
25. Scully Crispian: Immunologic abnormalities in oral carcinoma and oral keratosis. J. Max Fac Surg, 1982, 113-115.
26. Gross, L.: Immunological defect in the aged population and its relationship to cancer. Cancer 1965,18:201-6
27. Ma, R. H: Increased lysyl oxidase activity in fibroblasts cultured from OSMF. J. Oral Pathol Med., 1995, 9, 407-12
28. Jaydeep, A.: Serum levels of copper, zinc, iron and ceruloplasumin in oral leukoplakia and sq. cell carcinoma. J. Exp. Clin Cancer Res., 1997, 16(3).
29. Huang, S.; Ling T; Wu, H.: Experimental study on aqueous areca nut extracts inducing OSMF in rats. In: Effect of mast cells on collagen metabolism, Hua Xi et al, 1997, 15(2), 94-96
30. Ramanthan, K.: OSMF - an alternative hypothesis to its cause. Med J Malay, 1981, 36(4), 243-45
31. Shamberger, R. J.: Antioxidants and Cancer. Arch Environ Health, 1976, 31, 231-33.
32. Yoshida, M.; Ota, Sachie; Fukunaga Kenji; Nishiyama Toshimasa: Molybdenum concentration in healthy Japanese adults determined by inductively coupled plasma-mass spectrometry. J. of Trace Elements in Biology, 20(1), 19-23.
33. Petersen, P. E.; Kwan, S.: Evaluation of community-based oral health promotion and oral disease prevention - WHO recommendations for improved evidence in public health practices. Community Dent Health, 2004, 21(Suppl 1), 319-20.